These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 1982265
21. Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues. Fitzgerald JL, Reid JJ. J Pharm Pharmacol; 1994 Oct; 46(10):826-32. PubMed ID: 7699571 [Abstract] [Full Text] [Related]
22. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. Chen NH, Reith ME. J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765 [Abstract] [Full Text] [Related]
23. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK. Eur J Pharmacol; 1989 Aug 29; 167(3):375-83. PubMed ID: 2572435 [Abstract] [Full Text] [Related]
24. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain. Riegert C, Wedekind F, Hamida SB, Rutz S, Rothmaier AK, Jones BC, Cassel JC, Jackisch R. Int J Neuropsychopharmacol; 2008 Sep 29; 11(6):743-63. PubMed ID: 18248690 [Abstract] [Full Text] [Related]
25. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Schmidt CJ, Black CK, Abbate GM, Taylor VL. Brain Res; 1990 Oct 08; 529(1-2):85-90. PubMed ID: 1980848 [Abstract] [Full Text] [Related]
26. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Feuerstein TJ, Hertting G, Lupp A, Neufang B. Br J Pharmacol; 1986 Jul 08; 88(3):677-84. PubMed ID: 3742155 [Abstract] [Full Text] [Related]
27. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA). Lowy MT, Nash JF, Meltzer HY. Eur J Pharmacol; 1989 Apr 12; 163(1):157-61. PubMed ID: 2472965 [Abstract] [Full Text] [Related]
28. Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Shankaran M, Gudelsky GA. Pharmacol Biochem Behav; 1998 Dec 12; 61(4):361-6. PubMed ID: 9802829 [Abstract] [Full Text] [Related]
29. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. Ricaurte GA, Martello AL, Katz JL, Martello MB. J Pharmacol Exp Ther; 1992 May 12; 261(2):616-22. PubMed ID: 1374470 [Abstract] [Full Text] [Related]
30. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS. J Pharmacol Exp Ther; 1987 Apr 12; 241(1):338-45. PubMed ID: 2883295 [Abstract] [Full Text] [Related]
31. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Battaglia G, Sharkey J, Kuhar MJ, de Souza EB. Synapse; 1991 Aug 12; 8(4):249-60. PubMed ID: 1681594 [Abstract] [Full Text] [Related]
32. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. Huang X, Nichols DE. Eur J Pharmacol; 1993 Jul 20; 238(2-3):291-6. PubMed ID: 8104811 [Abstract] [Full Text] [Related]
33. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors. Millan MJ, Colpaert FC. Eur J Pharmacol; 1991 Feb 07; 193(2):145-52. PubMed ID: 1675609 [Abstract] [Full Text] [Related]
34. MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors. Mlinar B, Mascalchi S, Morini R, Giachi F, Corradetti R. Neuropsychopharmacology; 2008 May 07; 33(6):1464-75. PubMed ID: 17653110 [Abstract] [Full Text] [Related]
35. MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum. Fischer HS, Zernig G, Schatz DS, Humpel C, Saria A. Eur J Neurosci; 2000 Apr 07; 12(4):1385-90. PubMed ID: 10762366 [Abstract] [Full Text] [Related]
36. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. Callaway CW, Wing LL, Geyer MA. J Pharmacol Exp Ther; 1990 Aug 07; 254(2):456-64. PubMed ID: 1974635 [Abstract] [Full Text] [Related]
37. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. Nash JF, Meltzer HY, Gudelsky GA. J Neurochem; 1990 Mar 07; 54(3):1062-7. PubMed ID: 1689375 [Abstract] [Full Text] [Related]
38. Newly synthesized noradrenaline mediates the alpha 2-adrenoceptor inhibition of [3H]5-hydroxytryptamine release induced by beta-phenylethylamine in rat hippocampal slices. Benkirane S, Arbilla S, Langer SZ. Eur J Pharmacol; 1986 Nov 19; 131(2-3):189-98. PubMed ID: 3028829 [Abstract] [Full Text] [Related]
39. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. Sacaan AI, Dunlop JL, Lloyd GK. J Pharmacol Exp Ther; 1995 Jul 19; 274(1):224-30. PubMed ID: 7542334 [Abstract] [Full Text] [Related]
40. Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. Cleary L, Docherty JR. Eur J Pharmacol; 2003 Aug 22; 476(1-2):31-4. PubMed ID: 12969746 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]